POSA319 Development of a Diminishing Marginal Disutility Model for Intravenous Iron Infusions Based on Data from a Time Trade-Off Study in China

Abstract

In patients with iron deficiency anemia (IDA), intravenous iron (IVI) is the preferred and most efficacious treatment when oral iron cannot be used or where rapid iron delivery is required; however, IV infusions are burdensome for patients and require them to travel to specialist infusion units, which can have a detrimental effect on patient quality of life (QoL). Also, the number of visits varies greatly between different IVI formulations. The aim of the present study was to quantify the magnitude of the effect of different annual infusion rates on QoL.